Nadifloxacin represents a crucial category for pharmaceutical analysis, encompassing this topical fluoroquinolone antibiotic primarily indicated for the treatment of acne vulgaris and bacterial skin infections.… Read more

![Chemical structure of 8-Amino-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F87488-29-7-8-Amino-9-fluoro-5-methyl-1-oxo-67-dihydro-1H5H-pyrido321-ijquinoline-2-carboxylic-Acid.png&w=3840&q=75)












Nadifloxacin represents a crucial category for pharmaceutical analysis, encompassing this topical fluoroquinolone antibiotic primarily indicated for the treatment of acne vulgaris and bacterial skin infections. This collection provides high-quality reference standards for the active pharmaceutical ingredient, alongside its related substances, including potential process-related impurities, stereoisomers such as levonadifloxacin, and synthetic intermediates. Pharmaceutical laboratories utilize these materials for comprehensive impurity profiling and the validation of analytical methods to ensure regulatory compliance. Furthermore, stable isotope labelled compounds, such as deuterium-labelled variants, serve as essential internal standards in mass spectrometry-based assays, allowing for precise quantification and structural verification. By offering these precise standards, this category supports the rigorous quality control and stability testing protocols required throughout the development and manufacturing lifecycle of fluoroquinolone-based dermatological formulations.